mRNA is transformational
We can positively impact the lives of millions of people
Our mRNA platform, with its speed, scale, and flexibility, is uniquely suited to tackle current and emerging pathogens that threaten global health.
Our Research Engine
Our Research Engine combines proprietary digital drug design tools and a highly automated production facility to enable Moderna to advance mRNA vaccines and therapeutics.
Scientists can select any protein in the human proteome to be engineered or they can design novel proteins. All can be designed to explore previously undiscovered pathways.
Our mRNA DESIGN STUDIO enables rapid design of multiple mRNAs.
As the DIGITAL BIOTECH COMPANY™, we maximize the utility of mRNA in our proprietary, web-based mRNA DESIGN STUDIO.
- Our scientists request mRNAs for a specific protein
- The protein target is automatically converted to an initial optimized mRNA sequence.
- Using our Sequence Designer module, they can tailor entire mRNAs from the 5’-UTR to the coding region to the 3’-UTR based on our ever-improving proprietary learnings.
- Our proprietary in-house digital application suite contains a Sequence Designer module to tailor an entire mRNA.
- mRNA DESIGN STUDIO utilizes cloud-based computational capacity to run various algorithms we have developed to design each mRNA sequence.
- The utility of cloud-based capacity allows us to provide flexible computational capacity on demand.
- This allows the Research Engine to power parallel intake and design of multiple mRNA sequences.
- The mRNA DESIGN STUDIO integrates with Moderna’s automation platforms–directing orders through each phase of mRNA synthesis.
- Once the order is placed, Moderna’s high-throughput mRNA pre-clinical production facility manages the manufacturing of mRNA constructs and delivers them in just weeks.
mRNA early development engine
Our services
Our mRNA EARLY DEVELOPMENT ENGINE™ services combine internal and external capabilities for process development, toxicology studies, global regulatory interactions, and clinical study preparation and execution for our mRNA vaccines and therapeutics.
These services are designed to deliver many investigational mRNA vaccines and therapeutics to human proof of concept data.